Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members, 61372-61373 [2013-24304]

Download as PDF 61372 Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices Massachusetts, Court of Federal Claims No: 13–0611V 45. Mordichai and Chana Pshemish on behalf of Y.P., Boca Raton, Florida, Court of Federal Claims No: 13– 0612V 46. Bryan Krehnbrink, Boston, Massachusetts, Court of Federal Claims No: 13–0613V 47. Saro Manoukian, Worcester, Massachusetts, Court of Federal Claims No: 13–0614V 48. Howard S. Kahn, Baraboo, Wisconsin, Court of Federal Claims No: 13–0615V 49. James E. Smith, Lake City, Tennessee, Court of Federal Claims No: 13–0617V 50. John Ryng, Bristol, Connecticut, Court of Federal Claims No: 13– 0618V 51. Ruth Day, Denton, Texas, Court of Federal Claims No: 13–0620V 52. Latasha George, Lake Charles, Louisiana, Court of Federal Claims No: 13–0621V 53. Danya Wright, Tarrant, Texas, Court of Federal Claims No: 13–0622V 54. Joseph Wojtanowski, Providence, Rhode Island, Court of Federal Claims No: 13–0623V 55. Cynthia M. Morris (Sabin), Dekalb, Illinois, Court of Federal Claims No: 13–0624V 56. Steven Carpenter, Lander, Wyoming, Court of Federal Claims No: 13– 0628V 57. Cathy L. Jackson, Raleigh, North Carolina, Court of Federal Claims No: 13–0630V 58. Douglas Orton on behalf of Walter J. Orton, III, Deceased, Grand Island, New York, Court of Federal Claims No: 13–0631V [FR Doc. 2013–24220 Filed 10–2–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members Health Resources and Services Administration, HHS. ACTION: Notice. tkelley on DSK3SPTVN1PROD with NOTICES AGENCY: The Health Resources and Services Administration (HRSA) is requesting nominations of qualified candidates to fill three vacancies on the Advisory Commission on Childhood Vaccines (ACCV). The ACCV was established by Title XXI of the Public SUMMARY: VerDate Mar<15>2010 18:29 Oct 02, 2013 Jkt 232001 Health Service Act (the Act), as enacted by Public Law (Pub. L.) 99–660 and as subsequently amended, and advises the Secretary of Health and Human Services (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). DATES: The agency must receive nominations on or before 60 days after date of publication in the Federal Register. ADDRESSES: All nominations are to be submitted to the Director, Division of Vaccine Injury Compensation, Healthcare Systems Bureau (HSB), HRSA, Parklawn Building, Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Ms. Amber Berrian, Principal Staff Liaison, Division of Vaccine Injury Compensation, HSB, HRSA, at (301) 443–0845 or email aberrian@hrsa.gov. SUPPLEMENTARY INFORMATION: Under the authorities that established the ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92–463) and section 2119 of the Act, 42 U.S.C. 300aa19, as added by Public Law 99–660 and amended, HRSA is requesting nominations for three voting members of the ACCV. The ACCV advises the Secretary on the implementation of the VICP. The activities of the ACCV include: Recommending changes in the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b); advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of the Vaccine Information Statements; and recommending to the Director of the National Vaccine Program that vaccine safety research be conducted on various vaccine injuries. The ACCV consists of nine voting members appointed by the Secretary as follows: (1) Three health professionals, who are not employees of the United States Government and have expertise in the health care of children, and the epidemiology, etiology, and prevention of childhood diseases, and the adverse PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 reactions associated with vaccines, at least two shall be pediatricians; (2) three members from the general public, at least two shall be legal representatives (parents or guardians) of children who have suffered a vaccine-related injury or death; and (3) three attorneys, at least one shall be an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death, and one shall be an attorney whose specialty includes representation of vaccine manufacturers. In addition, the Director of the National Institutes of Health, the Assistant Secretary for Health, the Director of the Centers for Disease Control and Prevention, and the Commissioner of the Food and Drug Administration (or the designees of such officials) serve as nonvoting ex officio members. Specifically, HRSA is requesting nominations for three voting members of the ACCV representing: (1) A health professional, who has expertise in the health care of children; and the epidemiology, etiology, and prevention of childhood diseases; and (2) a member of the general public who is the legal representative (parent or guardian) of a child who has suffered a vaccine related injury or death; and (3) an attorney with no specific affiliation. Nominees will be invited to serve a 3-year term beginning January 1, 2014, and ending December 31, 2016. The Department of Health and Human Services (HHS) will consider nominations of all qualified individuals with a view to ensuring that the ACCV includes the areas of subject matter expertise noted above. Individuals may nominate themselves or other individuals, and professional associations and organizations may nominate one or more qualified persons for membership on the ACCV. Nominations shall state that the nominee is willing to serve as a member of the ACCV and appears to have no conflict of interest that would preclude the ACCV membership. Potential candidates will be asked to provide detailed information concerning financial interests, consultancies, research grants, and/or contracts that might be affected by recommendations of the ACCV to permit evaluation of possible sources of conflicts of interest. A nomination package should include the following information for each nominee: (1) A letter of nomination stating the name, affiliation, and contact information for the nominee, the basis for the nomination (i.e., what specific attributes, perspectives, and/or skills does the individual possess that would benefit the workings of ACCV), and the nominee’s field(s) of expertise; (2) a E:\FR\FM\03OCN1.SGM 03OCN1 Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices biological sketch of the nominee and a copy of his/her curriculum vitae; and (3) the name, address, daytime telephone number, and email address at which the nominator can be contacted. HHS strives to ensure that the membership of HHS federal advisory committee is fairly balanced in terms of points of view presented and the committees function. Every effort is made to ensure that the views of women, all ethnic and racial groups, and people with disabilities are represented on HHS federal advisory committees and, therefore, the Department encourages nominations of qualified candidates from these groups. The Department also encourages geographic diversity in the composition of the Committee. Appointment to this Committee shall be made without discrimination on basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Dated: September 26, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–24304 Filed 10–2–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Animal Center Master Plan Record of Decision The Department of Health and Human Services, the National Institutes of Health (NIH), has decided, after completion of a Final Environmental Impact Statement (FEIS) and a thorough consideration of the public comments on the Draft EIS, to implement the Proposed Action, referred to as the Proposed Action in the Final EIS. This action is for a long-range physical Master Plan for National Institutes of Health Animal Center (NIHAC) located in Dickerson, Maryland. This alternative accounts for potential growth in NIHAC personnel, new construction, additions, renovations, demolitions, and upgrades in site utilities. Responsible Official: Daniel G. Wheeland, Director, Office of Research Facilities Development and Operations, NIH. FOR FURTHER INFORMATION CONTACT: Valerie Nottingham, Deputy Director, DEP, ORF, NIH, Building 13, Room 2S11, 9000 Rockville Pike, Bethesda, MD 20892, Phone 301–496–7775, nihnepa@mail.nih.gov. SUPPLEMENTARY INFORMATION: tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:29 Oct 02, 2013 Jkt 232001 Decision After careful review of the environmental consequences in the Final Environmental Impact Statement for the Master Plan, National Institutes of Health Animal Center, and consideration of public comment throughout the NEPA process, the NIH has decided to implement the Proposed Action described below as the Selected Alternative. Selected Alternative The Selected Alternative is intended to be a strategic tool for the efficient allocation of campus resources, the orderly accommodation of future growth, and the creation of an environment, which is both functionally and aesthetically conducive to accomplishing the NIHAC mission. The Selected Alternative will provide a guide for the reasoned and orderly development of the NIHAC campus, one that values and builds on existing resources, corrects current deficiencies and meets changing needs through new construction or renovation. The plan sets forth implementation priorities and a logical sequencing of planned development. The Selected Alternative is for a longrange physical Master Plan for NIHAC. This alternative covers a 20-year planning period, with reviews every 5 years to ensure that the plan continues to address issues affecting the campus. The alternative addresses the future development of the NIHAC site, including placement of future construction; vehicular and pedestrian circulation on and off-campus; parking within the property boundaries; open space in and around the campus; required setbacks; historic properties; natural and scenic resources; noise; and lighting. This alternative accounts for potential growth in NIHAC personnel, and consequent construction of space over the planning period. Future construction on the site could include such facilities as new animal holding, research laboratories, and support facilities. NIH will continue to develop NIHAC to accommodate NIH’s research needs and required programmatic adjacencies consistent with the commitment to maintain the ‘‘campus’’ character of the site. The alternative advances this objective by programming and locating future NIHAC growth so that new development would tie into the existing utility services and utilities are available to support growth, and establishing development guidelines for future changes to the site that ensure that as the campus grows new development PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 61373 would be responsive to the context of adjacent neighborhoods or developments. Under the selected alternative, NIHAC’s population is anticipated to grow in the next twenty years to a total campus population of 212. The primary growth at the campus would be in intramural research personnel and the administrative and facility staff to support them. Alternatives Considered The Proposed Action Alternative and No Action Alternative were the two alternatives analyzed in the Final EIS. The Master Plan covers a 20-year planning period, but will be reviewed every 5 years to ensure that the plan continues to remain current and relevant to the key issues affecting the campus. The alternatives addressed the future development of the NIHAC site, including placement of future construction; vehicular and pedestrian circulation on and off-campus; parking within the property boundaries; open space in and around the campus; required setbacks; historic properties; natural and scenic resources; noise; and lighting. They account for potential growth in NIHAC personnel, and consequent construction of space over the planning period. Future construction on the site could include such facilities as new animal holding, research laboratories, and support facilities. Factors Involved in the Decision The Department of Health and Human Services (HHS) requires that NIH facilities have a Master Plan; however, the previous Master Plan for the NIHAC campus was outdated. In addition, factors such as the aging of facilities that were designed only to accommodate temporary use, animal housing facilities that do not provide adequate space for projected increases in animal populations, and research support facilities not being adequate to sustain current and projected programs played a key role. The Master Plan contains information and recommendations to guide development of individual projects. It also serves as a means of informing city and county officials and utilities of future NIHAC development plans so they can anticipate and plan for the potential effects of NIHAC proposals on their systems. Resources Impacts The Final EIS describes potential environmental effects of the Selected Alternative. These potential effects are documented in Chapter 3 of the Final EIS. Any potential adverse environmental effects will be avoided or E:\FR\FM\03OCN1.SGM 03OCN1

Agencies

[Federal Register Volume 78, Number 192 (Thursday, October 3, 2013)]
[Notices]
[Pages 61372-61373]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24304]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission of Childhood Vaccines; Request for 
Nominations for Voting Members

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations of qualified candidates to fill three vacancies 
on the Advisory Commission on Childhood Vaccines (ACCV). The ACCV was 
established by Title XXI of the Public Health Service Act (the Act), as 
enacted by Public Law (Pub. L.) 99-660 and as subsequently amended, and 
advises the Secretary of Health and Human Services (the Secretary) on 
issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP).

DATES: The agency must receive nominations on or before 60 days after 
date of publication in the Federal Register.

ADDRESSES: All nominations are to be submitted to the Director, 
Division of Vaccine Injury Compensation, Healthcare Systems Bureau 
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane, 
Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Ms. Amber Berrian, Principal Staff 
Liaison, Division of Vaccine Injury Compensation, HSB, HRSA, at (301) 
443-0845 or email aberrian@hrsa.gov.

SUPPLEMENTARY INFORMATION: Under the authorities that established the 
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 
92-463) and section 2119 of the Act, 42 U.S.C. 300aa-19, as added by 
Public Law 99-660 and amended, HRSA is requesting nominations for three 
voting members of the ACCV.
    The ACCV advises the Secretary on the implementation of the VICP. 
The activities of the ACCV include: Recommending changes in the Vaccine 
Injury Table at its own initiative or as the result of the filing of a 
petition; advising the Secretary in implementing section 2127 regarding 
the need for childhood vaccination products that result in fewer or no 
significant adverse reactions; surveying federal, state, and local 
programs and activities related to gathering information on injuries 
associated with the administration of childhood vaccines, including the 
adverse reaction reporting requirements of section 2125(b); advising 
the Secretary on the methods of obtaining, compiling, publishing, and 
using credible data related to the frequency and severity of adverse 
reactions associated with childhood vaccines; consulting on the 
development or revision of the Vaccine Information Statements; and 
recommending to the Director of the National Vaccine Program that 
vaccine safety research be conducted on various vaccine injuries.
    The ACCV consists of nine voting members appointed by the Secretary 
as follows: (1) Three health professionals, who are not employees of 
the United States Government and have expertise in the health care of 
children, and the epidemiology, etiology, and prevention of childhood 
diseases, and the adverse reactions associated with vaccines, at least 
two shall be pediatricians; (2) three members from the general public, 
at least two shall be legal representatives (parents or guardians) of 
children who have suffered a vaccine-related injury or death; and (3) 
three attorneys, at least one shall be an attorney whose specialty 
includes representation of persons who have suffered a vaccine-related 
injury or death, and one shall be an attorney whose specialty includes 
representation of vaccine manufacturers. In addition, the Director of 
the National Institutes of Health, the Assistant Secretary for Health, 
the Director of the Centers for Disease Control and Prevention, and the 
Commissioner of the Food and Drug Administration (or the designees of 
such officials) serve as nonvoting ex officio members.
    Specifically, HRSA is requesting nominations for three voting 
members of the ACCV representing: (1) A health professional, who has 
expertise in the health care of children; and the epidemiology, 
etiology, and prevention of childhood diseases; and (2) a member of the 
general public who is the legal representative (parent or guardian) of 
a child who has suffered a vaccine related injury or death; and (3) an 
attorney with no specific affiliation. Nominees will be invited to 
serve a 3-year term beginning January 1, 2014, and ending December 31, 
2016.
    The Department of Health and Human Services (HHS) will consider 
nominations of all qualified individuals with a view to ensuring that 
the ACCV includes the areas of subject matter expertise noted above. 
Individuals may nominate themselves or other individuals, and 
professional associations and organizations may nominate one or more 
qualified persons for membership on the ACCV. Nominations shall state 
that the nominee is willing to serve as a member of the ACCV and 
appears to have no conflict of interest that would preclude the ACCV 
membership. Potential candidates will be asked to provide detailed 
information concerning financial interests, consultancies, research 
grants, and/or contracts that might be affected by recommendations of 
the ACCV to permit evaluation of possible sources of conflicts of 
interest.
    A nomination package should include the following information for 
each nominee: (1) A letter of nomination stating the name, affiliation, 
and contact information for the nominee, the basis for the nomination 
(i.e., what specific attributes, perspectives, and/or skills does the 
individual possess that would benefit the workings of ACCV), and the 
nominee's field(s) of expertise; (2) a

[[Page 61373]]

biological sketch of the nominee and a copy of his/her curriculum 
vitae; and (3) the name, address, daytime telephone number, and email 
address at which the nominator can be contacted.
    HHS strives to ensure that the membership of HHS federal advisory 
committee is fairly balanced in terms of points of view presented and 
the committees function. Every effort is made to ensure that the views 
of women, all ethnic and racial groups, and people with disabilities 
are represented on HHS federal advisory committees and, therefore, the 
Department encourages nominations of qualified candidates from these 
groups. The Department also encourages geographic diversity in the 
composition of the Committee. Appointment to this Committee shall be 
made without discrimination on basis of age, race, ethnicity, gender, 
sexual orientation, disability, and cultural, religious, or 
socioeconomic status.

    Dated: September 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-24304 Filed 10-2-13; 8:45 am]
BILLING CODE 4165-15-P